Search

Search Results for "biosimilars"

New Retina Radio Journal Club: Biosimilars in Wet AMD

Thumbnail for prbir

A Role for Biosimilars in Retina?

Alay S. Banker, MD, Charles C. Wykoff, MD, PhD, FACS

Biosimilars in Retina thumbnail

Biosimilars in Retina

Ramin Tadayoni, MD, PhD, and Prof. Frank Holz

Biosimilars in Retina: A Pair of Phase 3 Papers thumbnail

New Retina Radio Journal Club: Biosimilars in Retina: A Pair of Phase 3 Papers

Yasha Modi, MD; Kyle Kovacs, MD; Priya Vakharia, MD

Biosimilars in the Real World thumbnail

Biosimilars in the Real World

Carl C. Awh, MD, FASRS

Biosimilars in Retina: Clinical Pearls thumbnail

Biosimilars in Retina: Clinical Pearls

Susan Bressler, MD; and Timothy G. Murray, MD, MBA

How Did We Get Here? thumbnail

How Did We Get Here?

Marc R. Bloomenstein, OD, FAAO

Next-Gen Therapies for AMD and DME thumbnail

Next-Gen Therapies for AMD and DME

Nicole Eter, MD

Harrow Adds Biosimilars to US Portfolio

AAO '22: Biosimilars’ Practice Implications and Year 2 of YOSEMITE/RHINE

George Williams, MD, and Caroline Baumal, MD

The State of Biosimilars: How We Got Here and What It Means for Practice

John Kitchens, MD; Carl Awh, MD; Firas Rahhal, MD

The State of Biosimilars: Integration of Biosimilars into a Retina Practice

John W. Kitchens, MD (Moderator); David Brown, MD; and Kristin Yockus

New Retina Radio Journal Club: Biosimilars in Retina: A Pair of Phase 3 Papers

Yasha Modi, MD; Kyle Kovacs, MD; and Priya Vakharia, MD

New Retina Radio Journal Club: Biosimilars in Wet AMD

Aleksandra Rachitskaya, MD; Emmanuel Chang, MD, PhD; Michael Klufas, MD; and Dmitra Skondra, MD

Art of Drug Choice: The Latest Advances in Wet AMD Therapy

Arshad M. Khanani, MD, MA; Lejla Vajzovic, MD, and Joseph M. Coney, MD

AAO '22 Late-Breaking Talks: Biosimilar Phase 3 Data and TRUCKEE Update

Anat Loewenstein, MD; and Ramanath Bhandari, MD

Eylea HD Approved for RVO and Extended Dosing

Norlase Launches First Pattern Scanning LIO

Staar Terminates Merger with Alcon

View More